Live from the NIH registry
Studies recruiting near Worcester right now
Top 25 of 273 recruiting studies, sorted by proximity — each links to its official registry page
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Vitalix — Worcester, Massachusetts (0.6 mi)
· Sponsor: Teikoku Pharma USA, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Radiation Free Study
Aortic Aneurysm
N/A
Interventional 182 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Philips Clinical & Medical Affairs Global
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Kura Oncology, Inc.
Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients
Non-segmental Vitiligo
Phase 2
Interventional 45 participants sought
U Mass Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: SWOG Cancer Research Network
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Alabama at Birmingham
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Massachusetts Memorial Health — Worcester, Massachusetts (0.6 mi)
· Sponsor: Lupus Research Alliance
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Worcester, Massachusetts (0.6 mi)
· Sponsor: AstraZeneca
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Eli Lilly and Company
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection Recurrence
Phase 2
Interventional 20 participants sought
University of Massachusetts Memorial Healthcare — Worcester, Massachusetts (0.6 mi)
· Sponsor: Acurx Pharmaceuticals Inc.
Intravenous Iron Effects on Performance at High Altitude
Hypoxia
Phase 4
Interventional 24 participants sought
USARIEM — Natick, Massachusetts (23.5 mi)
· Sponsor: United States Army Research Institute of Environmental Medicine
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Magenta Medical Ltd.
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 614 participants sought
University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144) — Worcester, Massachusetts (0.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
PTSD, Alcohol; Use, Problem
N/A
Interventional 144 participants sought
University of Massachusetts Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
Periodontal Diseases, Periodontitis
N/A
Interventional 70 participants sought
Acton Dental Associates — Acton, Massachusetts (24.2 mi)
· Sponsor: Erchonia Corporation
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
COPD (Chronic Obstructive Pulmonary Disease)
N/A
Interventional 50 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
Major Depressive Disorder
Phase 2
Interventional 164 participants sought
Vitalix Clinical — Worcester, Massachusetts (0.6 mi)
· Sponsor: Syndeio Biosciences, Inc
Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer
Colorectal Neoplasms
Phase 3
Interventional 300 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Surgimab
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Reliant Medical Group Inc — Worcester, Massachusetts (0.6 mi)
· Sponsor: Amgen
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
Migraine
Phase 3
Interventional 200 participants sought
New England Regional Headache Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
Preliminary Trial of an Avatar Guided Digital Intervention for Emerging Adults
Binge Alcohol Consumption, Suicidal Ideation
N/A
Interventional 60 participants sought
UMass Memorial Health - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction
Heart Failure With Preserved Ejection Fraction
Phase 3
Interventional 2,000 participants sought
Charles River Medical Associates — Natick, Massachusetts (23.5 mi)
· Sponsor: Uppsala University
Letrozole in Uterine Leiomyosarcoma
Uterine Leiomyosarcoma
Phase 2
Interventional 40 participants sought
University of Massachusetts Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: GOG Foundation